Ronald Asbury Andrews, Director at Oxford Immunotec, holds 7.46K shares in Precipio (Ticker: PRPO), holds 583.21K shares in OncoCyte (Ticker: OCX), holds 0.00 shares in Oxford Immunotec (Ticker: OXFD).

See the Hottest Stocks Based on Insider Trading >

Ronald Asbury Andrews
Oxford Immunotec (OXFD)
Director

Ranked #22,329 out of 98,624 Corporate Insiders

Profitable Transactions

2 out of 5 Profitable Transactions

Average Return

+13.10%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

96.99%

OCX

3.01%

PRPO

A breakdown of Ronald Asbury Andrews's holdings

See the Top Stocks by Insiders

Insider Roles

OncoCyte
(OCX)

Former CEO, Director

Precipio
(PRPO)

Director

Roles that Ronald Asbury Andrews holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

OncoCyte
(OCX)

Rating:Informative Buy

Date:Apr 01, 2020 - Apr 01, 2021

Return:+149.50%

The most profitable trade made by Ronald Asbury Andrews

See the Latest Stocks Traded by Insiders

Ronald Asbury Andrews's Trading History

OXFD

Oxford Immunotec

Mar 12, 2021

―

Uninformative Sell

89.78K

$0.00

OCX

OncoCyte

Aug 18, 2022

Former CEO, Director

Informative Buy

38.40K

$1.45M

PRPO

Precipio

Apr 17, 2024

Director

Uninformative Buy

21.00K

$44.95K

~LIFE

Life Technologies Corp

Feb 04, 2014

―

Uninformative Sell

560.09K

―

List of latest transactions for each holding click on a transaction to see Ronald Asbury Andrews's performance on stock

See All Insider Trading from Today

Ronald Asbury Andrews insider profile FAQ

What is the percentage of profitable transactions made by Ronald Asbury Andrews?

The percentage of profitable transactions made by Ronald Asbury Andrews is 40%.

What is the average return per transaction made by Ronald Asbury Andrews?

The average return per transaction made by Ronald Asbury Andrews is 13.10%.

What stocks does Ronald Asbury Andrews hold?

Ronald Asbury Andrews holds: OXFD, OCX, PRPO, ~LIFE stocks.

What was Ronald Asbury Andrews’s latest transaction?

Ronald Asbury Andrews latest transaction was an Uninformative Buy of $21.00K.

What was Ronald Asbury Andrews's most profitable transaction?

Ronald Asbury Andrews’s most profitable transaction was an Informative Buy of OCX stock on April 1, 2020. The return on the trade was 149.50%.

What is Ronald Asbury Andrews's role in Oxford Immunotec?

Ronald Asbury Andrews's role in Oxford Immunotec is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Ronald Asbury Andrews Insider Profile

Ronald Asbury Andrews Oxford Immunotec (OXFD)Director